|
|
SFX by Ex Libris Inc.
|
List of services to meet your request
|
|||||||||||||
|
|||||||||||||
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
![](https://beacon01.alma.exlibrisgroup.com/boom/apache_pb.gif?SRVR=adz.izum.si&IP=193.2.126.232&A=SFX&P=SFXMenu&S=s2BE7E7EA-587B-11EF-827E-8DAC84CE164B&I=39IZM&T=&OP=Display&O=html&O1=14885095&O2=5070000000002545&O3=&O4=summon.serialssolutions.com&O5=https%3A%2F%2Fadz.izum.si%2Fsfxlcl41%3Fctx_enc%3Dinfo%253Aofi%252Fenc%253AUTF-8%26ctx_ver%3DZ39.88-2004%26rfr_id%3Dinfo%253Asid%252Fsummon.serialssolutions.com%26rft.atitle%3DProgression%2520of%2520prostate%2520cancer%2520reprograms%2520MYC-mediated%2520lipid%2520metabolism%2520via%2520lysine%2520methyltransferase%25202A%26rft.au%3DCapaldo%252C%2520Brian%2520J%26rft.au%3DKu%252C%2520Anson%2520T%26rft.au%3DWhite%252C%2520Margaret%2520E%26rft.au%3DWhitlock%252C%2520Nichelle%2520C%26rft.date%3D2022-10-01%26rft.eissn%3D2730-6011%26rft.epage%3D97%26rft.externalDBID%3DNO_FULL_TEXT%26rft.genre%3Darticle%26rft.issue%3D1%26rft.jtitle%3DDiscover.%2520Oncology%26rft.spage%3D97%26rft.volume%3D13%26rft_id%3Dinfo%253Adoi%252F10.1007%252Fs12672-022-00565-3%26rft_val_fmt%3Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal&O6=1-SPRINGER_LINK_JOURNALS_AUTOLOAD_konzorcij_20230517_LCL-getFullTxt-object,2-UNPAYWALL-getFullTxt-object,3-PUBMED_CENTRAL_JOURNALS-getFullTxt-object,4-DOAJ_DIRECTORY_OPEN_ACCESS_JOURNALS-getFullTxt-object,5-EZB-FREE-00999_FREELY_AVAILABLE_EZB_JOURNALS-getFullTxt-object,6-PROQUEST_CENTRAL-getFullTxt-object,7-PUBMED_CENTRAL_OPEN_ACCESS_FREE-getFullTxt-object,8-DOI-getDOI-object,9-COBIB_SI_LCL-getHolding-object,10-REFWORKS_EXPORT_TOOL-getReference-object,11-GOOGLE_SCHOLAR_FREE-getWebSearch-object,12-WWW_SEARCH_ENGINES_FREE-getWebSearch-object&O7=1.636437&O8=N&O9=<ctx:context-object identifier="urn:sfxstat:14885095-s2BE7E7EA-587B-11EF-827E-8DAC84CE164B" timestamp="2024-08-12T09:19:19Z" xmlns:ctx="info:ofi/fmt:xml:xsd:ctx">
<ctx:referent>
<ctx:identifier>urn:sfxid:5070000000002545</ctx:identifier>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:journal</ctx:format>
<ctx:metadata>
<jnl:journal xmlns:jnl="info:ofi/fmt:xml:xsd:journal">
<jnl:atitle>Progression of prostate cancer reprograms MYC-mediated lipid metabolism via lysine methyltransferase 2A</jnl:atitle>
<jnl:jtitle>Discover Oncology</jnl:jtitle>
<jnl:date>2022-12-00</jnl:date>
<jnl:spage>97</jnl:spage>
<jnl:epage>97</jnl:epage>
<jnl:volume>13</jnl:volume>
<jnl:issue>1</jnl:issue>
<jnl:genre>article</jnl:genre>
<jnl:eissn>2730-6011</jnl:eissn>
<jnl:language>eng</jnl:language>
<jnl:authors></jnl:authors>
</jnl:journal>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:referent>
<ctx:requester>
<ctx:identifier>urn:ip:609347bb8c6932f58dead94ab07b4c302656cf77</ctx:identifier>
<ctx:identifier>urn:UUID:s2BE7E7EA-587B-11EF-827E-8DAC84CE164B</ctx:identifier>
</ctx:requester>
<ctx:referrer>
<ctx:identifier>info:sid/summon.serialssolutions.com</ctx:identifier>
</ctx:referrer>
<ctx:service-type>
<ctx:metadata-by-val>
<ctx:format>info:ofi/fmt:xml:xsd:svcList</ctx:format>
<ctx:metadata>
<svc:svcList xmlns:svc="http://www.exlibrisgroup.com/schema/info:ofi/fmt:xml:xsd:sch_svc"></svc:svcList>
</ctx:metadata>
</ctx:metadata-by-val>
</ctx:service-type>
<ctx:resolver>
<ctx:identifier>https://adz.izum.si/sfxlcl41</ctx:identifier>
</ctx:resolver>
</ctx:context-object>
&)